|BioCardia is a biotherapeutic platform and product company based on fully developed medical device technologies.|
BioCardia is engaged in two core businesses:
Helix Biotherapeutic Delivery offers a catheter system for the local delivery of cells, gene, and protein therapeutics to the heart.
Morph Access Innovations develops advanced catheter products for interventional medicine.
November 18, 2013
AccessPro Steerable Introducer Article in March 2011 Endovascular Today by Dr. Frank Arko et al.
January 6, 2011
BioCardia elects Jay M. Moyes to Board of Directors
November 18, 2010
BioCardia Announces CE Mark Approval